KRAS and colorectal carcinoma: By transcriptionally up-regulating the expression of KRAS, BRAF, and c-Myc, we demonstrate that PHF8 predominantly has an oncogenic effect in KRAS- or BRAF-mutant CRC cells but not in wild-type cells.